Exobiosphere

EXOBIOSPHERE, founded in 2024 in Luxembourg, aims to transform the drug discovery process by utilizing the unique advantages of microgravity environments. The company provides a platform that unlocks new insights into cellular behaviors not observable under Earth's gravity. These insights are harnessed to accelerate the development of novel therapeutics, ultimately improving human health both on Earth and in space. EXOBIOSPHERE serves clients in the pharmaceutical, skincare, and nutrition sectors, offering an efficient, dependable, and safe gateway for space-based research. The company's business model revolves around providing the tools and insights necessary for clients to develop new, effective therapies more rapidly and cost-effectively than traditional methods. Revenue is generated through service fees for access to their microgravity research platform and associated support services.

Keywords: microgravity, drug discovery, novel therapeutics, cellular behaviors, pharmaceuticals, skincare, nutrition, space-based research, rapid development, cost-effective.